ONE-YEAR FOLLOW-UP OF COMBINED CUSTOMIZED THERAPY. PHOTODYNAMIC THERAPY AND BEVACIZUMAB FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION | Publicación